Gerald Evans

Dr. Gerald Evans is a Canadian physician and infectious diseases specialist based in Kingston, Ontario.

Evans is the Chair of the Division of Infectious Diseases and a Professor in the Departments of Medicine, Biomedical & Molecular Sciences and Pathology & Molecular Medicine at Queen’s University. He was initially appointed to a faculty position at Queen’s in 1990.¹⁾

Evans was the President of the Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada) from 2009-2011, and is currently the Editor-in-Chief of the Official Journal of the Association of Microbiology and Infectious Disease Canada.

He is also the former Chair of the Guidelines Committee of AMMI Canada.²⁾

Evans is an attending physician in Infectious Diseases at Kingston Health Sciences Centre, Hotel Dieu Hospital, and Providence Care Hospital.³⁾ Dr. Evans has been Medical Director of Infection Prevention & Control at the facilities since 2011.

The facilities are funded through the University Hospitals Kingston Foundation by AmerisourceBergen, Amgen, AstraZeneca, Baxter, Bayer, Bell, BMO Financial Group, Boehringer Ingelheim, Canadian Cancer Society, CIBC, Corus Entertainment, Costco, Covidien, General Electric, IBM, Imperial Oil, Janssen, Johnson & Johnson, KPMG, LEO Pharma, Loblaws, Manulife Financial, Medtronic, Novartis, Novopharm, Ortho Biotech, Paladin Laboratories, PepsiCo, Pfizer, Queen's University, RBC (Royal Bank of Canada), RBC Foundation, Rogers Media, Ronald McDonald House Charities, Sanofi, Scotiabank, Shoppers Drug Mart, St. Jude Medical, Sun Life Financial, TC Energy, TD Bank Group, and TELUS.⁴⁾

Evans is the immediate past Chair of the Committee to Evaluate Drugs of the Ontario Ministry of Health and Long-Term Care, the Ministry’s expert advisory committee on optimal drug utilization for the province of Ontario. He also serves as Chair of the Working Group on Drugs for Rare Diseases for the MOHLTC.

Evans is an Affiliate Scientist at the Institute for Clinical Evaluative Sciences.⁵⁾

Evans is an Infection Prevention and Control (IPAC) consultant physician with Public Health Ontario.

Evans is a member of the Cancer Care Ontario subcommittee under Ontario Health.⁶⁾

Evans is a co-investigator with the Ontario Drug Policy Research Network (ODPRN), hosted at St. Michael's Hospital in Toronto.⁷⁾

Evans is a member of the Expert Committee for Reformulary, an evidence-based list of drugs reviewed and recommended by the panel.⁸⁾

Evans has participated as a speaker at the Critical Care Canada Forum, the official meeting of the Canadian Critical Care Society.⁹⁾ The Forum's 2021 webinars were sponsored by Medtronic, Merck, Paladin Laboratories, and Masimo.¹⁰⁾

Evans is a co-applicant on a grant for the Canadian Lyme Disease Research Network, the project formerly led by Dr. Kieran Moore.¹¹⁾

Evans is a member of the Ontario COVID-19 Science Advisory Table, including as a member of the Behavioural Science Working Group.¹²⁾

Evans received research funding from the Southeastern Ontario Academic Medical Organization (SOAMO) for “synthesis and preclinical testing of novel small molecule therapies for COVID‐19.”¹³⁾

Evans has received research funding from Biocryst.¹⁴⁾